Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Han

Showing results (61-70 of 102) with videos related to

Pageof 11
Sort By:
Journal of Personalized Medicine|February 25, 2023
Positive Clinical Outcomes for Severe Reported Pain Using Robust Non-Addictive Home Electrotherapy-A Case-SeriesAnish Bajaj, David Han, Igor Elman, et al.
Small (Weinheim an Der Bergstrasse, Germany)|November 27, 2025
Effect of Load on Non-Muscle Myosin 2 Paralog Filaments in a Biomimetic Contractile Actin ArrayPhilip Bleicher, David Han, Neil Billington, et al.
Food & Function|November 5, 2011
Correlation of the Taq1 dopamine D2 receptor gene and percent body fat in obese and screened control subjects: a preliminary reportAmanda L C Chen, Kenneth Blum, Thomas J H Chen, et al.
Plos One|September 24, 2014
Systematic evaluation of "compliance" to prescribed treatment medications and "abstinence" from psychoactive drug abuse in chemical dependence programs: data from the comprehensive analysis of reported drugsKenneth Blum, David Han, John Femino, et al.
Plos One|September 25, 2014
Menopause Analytical Hormonal Correlate Outcome Study (MAHCOS) and the association to brain electrophysiology (P300) in a clinical settingEric R Braverman, David Han, Marlene Oscar-Berman, et al.
British Journal of Clinical Pharmacology|July 29, 2021
Clinical evaluation of the potential drug-drug interactions of savolitinib: Interaction with rifampicin, itraconazole, famotidine or midazolamSong Ren, Karthick Vishwanathan, Mireille Cantarini, et al.
Clinical Drug Investigation|November 4, 2024
Pharmacokinetics and Tolerability of the Novel Myeloperoxidase Inhibitor Mitiperstat in Healthy Japanese and Chinese VolunteersMikael Sunnåker, Chandrali Bhattacharya, Karin Nelander, et al.
Clinical Pharmacology in Drug Development|June 9, 2016
Pharmacokinetic Effects of Isavuconazole Coadministration With the Cytochrome P450 Enzyme Substrates Bupropion, Repaglinide, Caffeine, Dextromethorphan, and Methadone in Healthy SubjectsTakao Yamazaki, Amit Desai, Ronald Goldwater, et al.
Heart (British Cardiac Society)|September 4, 2014
Exercise capacity in single-ventricle patients after Fontan correlates with haemodynamic energy loss in TCPCReza H Khiabani, Kevin K Whitehead, David Han, et al.
Clinical Pharmacology in Drug Development|June 9, 2016
Pharmacokinetic Interactions Between Isavuconazole and the Drug Transporter Substrates Atorvastatin, Digoxin, Metformin, and Methotrexate in Healthy SubjectsTakao Yamazaki, Amit Desai, Ronald Goldwater, et al.
Pageof 11

Showing results (61-70 of 102) with videos related to

Sort By:
Pageof 11
Journal of Personalized Medicine|February 25, 2023
Positive Clinical Outcomes for Severe Reported Pain Using Robust Non-Addictive Home Electrotherapy-A Case-SeriesAnish Bajaj, David Han, Igor Elman, et al.
Small (Weinheim an Der Bergstrasse, Germany)|November 27, 2025
Effect of Load on Non-Muscle Myosin 2 Paralog Filaments in a Biomimetic Contractile Actin ArrayPhilip Bleicher, David Han, Neil Billington, et al.
Food & Function|November 5, 2011
Correlation of the Taq1 dopamine D2 receptor gene and percent body fat in obese and screened control subjects: a preliminary reportAmanda L C Chen, Kenneth Blum, Thomas J H Chen, et al.
Plos One|September 24, 2014
Systematic evaluation of "compliance" to prescribed treatment medications and "abstinence" from psychoactive drug abuse in chemical dependence programs: data from the comprehensive analysis of reported drugsKenneth Blum, David Han, John Femino, et al.
Plos One|September 25, 2014
Menopause Analytical Hormonal Correlate Outcome Study (MAHCOS) and the association to brain electrophysiology (P300) in a clinical settingEric R Braverman, David Han, Marlene Oscar-Berman, et al.
British Journal of Clinical Pharmacology|July 29, 2021
Clinical evaluation of the potential drug-drug interactions of savolitinib: Interaction with rifampicin, itraconazole, famotidine or midazolamSong Ren, Karthick Vishwanathan, Mireille Cantarini, et al.
Clinical Drug Investigation|November 4, 2024
Pharmacokinetics and Tolerability of the Novel Myeloperoxidase Inhibitor Mitiperstat in Healthy Japanese and Chinese VolunteersMikael Sunnåker, Chandrali Bhattacharya, Karin Nelander, et al.
Clinical Pharmacology in Drug Development|June 9, 2016
Pharmacokinetic Effects of Isavuconazole Coadministration With the Cytochrome P450 Enzyme Substrates Bupropion, Repaglinide, Caffeine, Dextromethorphan, and Methadone in Healthy SubjectsTakao Yamazaki, Amit Desai, Ronald Goldwater, et al.
Heart (British Cardiac Society)|September 4, 2014
Exercise capacity in single-ventricle patients after Fontan correlates with haemodynamic energy loss in TCPCReza H Khiabani, Kevin K Whitehead, David Han, et al.
Clinical Pharmacology in Drug Development|June 9, 2016
Pharmacokinetic Interactions Between Isavuconazole and the Drug Transporter Substrates Atorvastatin, Digoxin, Metformin, and Methotrexate in Healthy SubjectsTakao Yamazaki, Amit Desai, Ronald Goldwater, et al.
Pageof 11